Staley Capital Advisers Inc. Sells 75,000 Shares of Option Care Health, Inc. $OPCH

Staley Capital Advisers Inc. decreased its holdings in Option Care Health, Inc. (NASDAQ:OPCH) by 25.0% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 225,000 shares of the company’s stock after selling 75,000 shares during the period. Staley Capital Advisers Inc.’s holdings in Option Care Health were worth $7,168,000 at the end of the most recent reporting period.

Other hedge funds have also recently made changes to their positions in the company. V Square Quantitative Management LLC bought a new position in shares of Option Care Health in the fourth quarter worth about $25,000. Cornerstone Planning Group LLC boosted its stake in shares of Option Care Health by 7,621.4% in the third quarter. Cornerstone Planning Group LLC now owns 1,081 shares of the company’s stock worth $30,000 after acquiring an additional 1,067 shares during the period. McIlrath & Eck LLC bought a new position in shares of Option Care Health in the second quarter worth about $37,000. Advisory Services Network LLC bought a new position in shares of Option Care Health in the third quarter worth about $35,000. Finally, Caitong International Asset Management Co. Ltd bought a new position in shares of Option Care Health in the third quarter worth about $38,000. Institutional investors own 98.05% of the company’s stock.

Analyst Upgrades and Downgrades

OPCH has been the subject of a number of recent analyst reports. Bank of America lowered Option Care Health from a “buy” rating to a “neutral” rating and set a $22.00 price objective for the company. in a research note on Friday, May 1st. Wall Street Zen lowered shares of Option Care Health from a “buy” rating to a “hold” rating in a research report on Saturday, February 28th. National Bank Financial set a $37.00 target price on shares of Option Care Health in a research report on Tuesday, January 27th. Barrington Research dropped their target price on shares of Option Care Health from $42.00 to $32.00 and set an “outperform” rating for the company in a research report on Friday, May 1st. Finally, TD Cowen dropped their target price on shares of Option Care Health from $37.00 to $23.00 and set a “hold” rating for the company in a research report on Friday, May 1st. One research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, three have issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $31.25.

Insider Buying and Selling at Option Care Health

In other Option Care Health news, Director Timothy P. Sullivan acquired 24,154 shares of the stock in a transaction on Thursday, May 7th. The stock was acquired at an average price of $20.69 per share, for a total transaction of $499,746.26. Following the completion of the transaction, the director directly owned 73,383 shares of the company’s stock, valued at $1,518,294.27. This trade represents a 49.06% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Harry M. Jansen Kraemer, Jr. acquired 36,610 shares of the stock in a transaction on Monday, May 4th. The shares were acquired at an average price of $21.41 per share, with a total value of $783,820.10. Following the transaction, the director directly owned 450,000 shares of the company’s stock, valued at $9,634,500. The trade was a 8.86% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Insiders acquired 73,264 shares of company stock worth $1,548,316 over the last 90 days. 1.70% of the stock is owned by insiders.

Option Care Health Price Performance

Shares of Option Care Health stock opened at $19.52 on Friday. The stock has a 50 day moving average of $26.84 and a 200 day moving average of $30.24. Option Care Health, Inc. has a 12 month low of $18.01 and a 12 month high of $36.80. The firm has a market cap of $3.07 billion, a PE ratio of 15.13, a PEG ratio of 1.09 and a beta of 0.68. The company has a current ratio of 1.64, a quick ratio of 1.07 and a debt-to-equity ratio of 0.85.

Option Care Health (NASDAQ:OPCH) last announced its quarterly earnings results on Thursday, April 30th. The company reported $0.40 EPS for the quarter, beating analysts’ consensus estimates of $0.37 by $0.03. Option Care Health had a return on equity of 18.17% and a net margin of 3.64%.The company had revenue of $1.35 billion during the quarter, compared to analyst estimates of $1.39 billion. During the same period in the prior year, the company earned $0.40 earnings per share. The firm’s revenue was up 1.3% on a year-over-year basis. Option Care Health has set its FY 2026 guidance at 1.820-1.920 EPS. On average, research analysts expect that Option Care Health, Inc. will post 1.64 EPS for the current fiscal year.

Option Care Health Company Profile

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.